Jeffrey Wingate
Orthopaedic Surgery of the Spine · Warren, MINPI 1235117524
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $48,279 of the $57,103 with a category attached, or 84.5%. Integrity Implants Inc. accounts for 76.6% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $28,428 and has fallen 98.2% since, to $506 in 2025.
Across 82 payments — averaging $696.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integrity Implants Inc.$44K
- Innovasis Inc$6K
- Integrity Implants Inc. Dba Accelus$5K
- Spine Wave, Inc.$471
- Captiva Spine Inc$430
- UCB, Inc.$339
- plus $1K from 14 others
What the payments were for
- Royalty or licence$48,27985%
- Travel & lodging$4,7648%
- Food & beverage$4,0167%
- Gifts$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integrity Implants Inc. | 21 | $43,757 |
| Innovasis Inc | 17 | $6,101 |
| Integrity Implants Inc. Dba Accelus | 6 | $4,923 |
| Spine Wave, Inc. | 7 | $471 |
| Captiva Spine Inc | 4 | $430 |
| UCB, Inc. | 9 | $339 |
| Kyocera Medical Technologies, Inc. | 1 | $270 |
| Spineology Inc. | 3 | $221 |
| Zimvie Inc. | 2 | $155 |
| AstraZeneca | 2 | $135 |
| Curonix LLC | 1 | $104 |
| Life Spine, Inc. | 1 | $67 |
| Amgen | 1 | $24 |
| Novartis | 1 | $22 |
| Pfizer | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Relievant Medsystems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,103 in reported general payments places this provider in the 75th percentile of 37 orthopaedic surgery of the spine providers in Michigan.
See all orthopaedic surgery of the spine providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 29 | $761 |
| Gabapentin | 36 | $546 |
| Tizanidine Hcl | 33 | $395 |
| Oxycodone Hcl | 12 | $392 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $288 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $255 |
| Pregabalin | 15 | $81 |
| Alprazolam | 15 | $65 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $49 |
| Mirtazapine | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Warren
- Martin KornblumWarren$866
- Peter BonoSouthfield$786K
- Joseph BrownGrand Rapids$565K
- Nilesh PatelDearborn$449K
- Michael KastenKalamazoo$261K
- John LamacchiaRochester$179K
- Joshua EllwitzKalamazoo$150K
- Michael KapsokavathisBirmingham$120K
- Michael DonahueAuburn Hills$96K
- Matthew KarekGrand Rapids$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.